REILLY FINANCIAL ADVISORS, LLC - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.

Quarter-by-quarter ownership
REILLY FINANCIAL ADVISORS, LLC ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q3 2016$2,000
+100.0%
700.0%0.00%
Q2 2016$1,000
-66.7%
70
-2.8%
0.00%
-100.0%
Q1 2016$3,000
-25.0%
72
+105.7%
0.00%0.0%
Q4 2015$4,000
-92.2%
35
-87.8%
0.00%
-88.9%
Q3 2015$51,000
-20.3%
2880.0%0.01%
-18.2%
Q2 2015$64,000
+12.3%
2880.0%0.01%
+10.0%
Q1 2015$57,000
+50.0%
2880.0%0.01%
+11.1%
Q1 2014$38,000
+11.8%
2880.0%0.01%
+12.5%
Q4 2013$34,0002880.01%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q3 2015
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,106,379$55,398,00031.67%
Claren Road Asset Management, LLC 80,000$2,820,00024.27%
Okumus Fund Management Ltd. 3,722,464$97,901,00015.82%
Wingspan Investment Management, LP 852,900$22,431,00012.66%
FARLEY CAPITAL L.P. 307,458$8,086,00011.46%
Chou Associates Management 976,843$25,725,0008.35%
Wingspan Investment Management, LP 550,700$14,483,0008.17%
HAP Trading, LLC 4,043,900$109,610,0008.00%
LeVasseur Capital Partners LLC 128,269$3,373,0006.97%
Pershing Square Capital Management 21,591,122$567,847,0006.41%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders